Pietrobon et al. used CRISPR/Cas9 gene editing to create human kidney organoids with homozygous knockout of either TSC1 or TSC2, and their study highlighted the essential roles of both genes in the development of renal manifestations associated with TSC [92]. The gene discussed is TSC2; the disease is tuberous sclerosis.